BioCentury
ARTICLE | Company News

Photocure, Salix deal

September 8, 2014 7:00 AM UTC

Photocure said it and Salix mutually agreed to terminate a 2010 deal granting Salix exclusive, worldwide rights, excluding the Nordic region, to develop and commercialize Lumacan hexaminolevulinate. ...